Pizzetti G, Carandente O, Passoni A, Ferrario A, Chierchia S L
Divisione di Cardiologia, Istituto Scientifico H S Raffaele, Milano.
Cardiologia. 1990 Oct;35(10):809-14.
Recent data suggest that nitrate compounds, beside determining vasodilatation by cGMP-mediated Ca++ uptake in the sarcoplasmic reticulum, may also inhibit vasoconstriction by reducing phosphatidyl inositol bisphosphate hydrolysis, a major step in the biochemical pathway responsible for vasoconstriction induced by a variety of agents including angiotensin II (AII). We assessed the inhibitory effects of Na-nitroprusside (NP) on the coronary resistances induced by increasing doses of AII in Krebs perfused (basal pressure: 2.5-3 KPa) Guinea-pig isolated hearts. AII bolus injections (5 to 100 ng) were given before and 10 min after a 7.6.10(-8) to 7.6.10(-6) M infusion of NP for 10 min. AII produced a highly reproducible, linearly dose-related, increase in perfusion pressure (PP) (5 ng: 4.4 +/- 1.16; 10 ng: 8.1 +/- 2.1; 25 ng: 18.7 +/- 3.06; 50 ng: 23.6 +/- 2.31; 100 ng: 30 +/- 1.37 mmHg) that was persistently and dose-dependently inhibited by NP. Well after (greater than 10 min) full recovery from the initial NP-induced vasodilatation and drop in PP its inhibitory effect was observed, varying from 22.1% at the maximal AII and minimal NP does and 90.6% at the minimal AII and maximal NP doses. This study demonstrates that, apart from causing the well-known immediate vasodilatory response by stimulation of cGMP synthesis, NP also causes delayed inhibition of AII-induced coronary vasoconstriction, possibly by preventing phosphatidyl inositol hydrolysis.
最近的数据表明,硝酸盐化合物除了通过环磷酸鸟苷(cGMP)介导的肌浆网钙离子摄取来决定血管舒张外,还可能通过减少磷脂酰肌醇二磷酸水解来抑制血管收缩,这是由包括血管紧张素II(AII)在内的多种因子诱导血管收缩的生化途径中的一个主要步骤。我们评估了硝普钠(NP)对在Krebs液灌注(基础压力:2.5 - 3千帕)的豚鼠离体心脏中,递增剂量AII诱导的冠状动脉阻力的抑制作用。在以7.6×10⁻⁸至7.6×10⁻⁶ M的浓度输注NP 10分钟之前和之后10分钟,分别给予AII推注(5至100纳克)。AII导致灌注压(PP)高度可重复、呈线性剂量相关地增加(5纳克:4.4±1.16;10纳克:8.1±2.1;25纳克:18.7±3.06;50纳克:23.6±2.31;100纳克:30±1.37毫米汞柱),而NP持续且剂量依赖性地抑制这种增加。在最初由NP诱导的血管舒张和PP下降完全恢复很久之后(大于10分钟),仍观察到其抑制作用,在最大AII和最小NP剂量时为22.1%,在最小AII和最大NP剂量时为90.6%。本研究表明,除了通过刺激cGMP合成引起众所周知的即刻血管舒张反应外,NP还可能通过阻止磷脂酰肌醇水解,导致对AII诱导的冠状动脉收缩的延迟抑制。